Literature DB >> 24684660

Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis.

C Tørring1, C Andreasen, N Gehr, L Bjerg, T Petersen, P Höllsberg.   

Abstract

OBJECTIVES: Epstein-Barr virus (EBV) infection is associated with multiple sclerosis (MS), and EBV may transform lymphoblastoid cell lines more frequently in MS patients than controls, but it is not clear whether this reflects a higher viral load or an enhanced ability to reactivate EBV.
MATERIAL AND METHODS: MS patients and controls were examined for their B-cell subsets and during 16 weeks for spontaneous lymphocyte transforming events.
RESULTS: MS patients had normal distribution of B-cell subsets, but a significantly higher incidence of B-cell transforming events, which occurred with kinetics similar to controls.
CONCLUSIONS: The higher incidence suggests an increased frequency of latent EBV-infected B cells in MS.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Epstein-Barr virus; lymphoblastoid cell lines; relapsing-remitting multiple sclerosis; switched memory B cells

Mesh:

Year:  2014        PMID: 24684660     DOI: 10.1111/ane.12249

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis.

Authors:  Y F Wang; D D He; H W Liang; D Yang; H Yue; X M Zhang; R Wang; B Li; H X Yang; Y Liu; Y Chen; Y X Duan; C Y Zhang; X Chen; J Fu
Journal:  Clin Exp Immunol       Date:  2017-03-28       Impact factor: 4.330

2.  Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.

Authors:  Caterina Veroni; Fabiana Marnetto; Letizia Granieri; Antonio Bertolotto; Clara Ballerini; Anna Maria Repice; Lucia Schirru; Giancarlo Coghe; Eleonora Cocco; Eleni Anastasiadou; Maria Puopolo; Francesca Aloisi
Journal:  J Neuroinflammation       Date:  2015-07-14       Impact factor: 8.322

Review 3.  Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.

Authors:  Michael P Pender; Scott R Burrows
Journal:  Clin Transl Immunology       Date:  2014-10-31

4.  Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

Authors:  Michael P Pender; Peter A Csurhes; Jacqueline M Burrows; Scott R Burrows
Journal:  Clin Transl Immunology       Date:  2017-01-20

5.  Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.

Authors:  Ali Afrasiabi; Grant P Parnell; Nicole Fewings; Stephen D Schibeci; Monica A Basuki; Ramya Chandramohan; Yuan Zhou; Bruce Taylor; David A Brown; Sanjay Swaminathan; Fiona C McKay; Graeme J Stewart; David R Booth
Journal:  Genome Med       Date:  2019-04-30       Impact factor: 11.117

Review 6.  Environmental Influencers, MicroRNA, and Multiple Sclerosis.

Authors:  Eiman Ma Mohammed
Journal:  J Cent Nerv Syst Dis       Date:  2020-01-20

Review 7.  CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.

Authors:  Manuel Ruiz-Pablos
Journal:  Pathogens       Date:  2022-07-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.